Pseudomonas aeruginosa

Antibiotic
% Susceptible
2010
% Susceptible
2012
% Susceptible
2014
% Susceptible
2016
% Susceptible
2018
Ampicillin
-
- - - -
Azithromycin
-
-
-
- -
Aztreonam
80
86
86
85 86
Cefazolin
-
-
-
- -
Cefepime
91
94
95
96 95
Ceftazidime
95
97
98
96 96
Ceftriaxone
32
37
17
- -
Cefuroxime
-
-
-
- -
Ciprofloxacin
82
80
86
87 90
Clarithromycin
-
-
-
- -
Clindamycin
-
-
-
- -
Doxycycline
-
-
-
- -
Erythromycin
-
-
-
- -
Gentamicin
82
93
88
81 90
Imipenem
93
96
96
93 91
Levofloxacin 81 79 84 85 89
Meropenem + 98 99 99 98
Moxifloxacin + + + + +
Nitrofurantoin - - - - -
Oxacillin/Naf - - - - -
Penicillin - - - - -
Piperacillin 97 99 100 + +
Piperacillin/tazo 98 99 100 99 99
Ticarcillin/Clav + + + + +
Tobramycin 97 99 99 99 99
TMP/SMX - - - - -
Unasyn/Aug - - - - -
Vancomycin - - - - -
       
# Tested 472 535 394 454 494

Comments:  

 

Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections